European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

9 EU fundings (€0.00): Liver Investigation: Testing Marker Utility in Steatohepatitis … BdlYear 2017 EU Research and Innovation programme "Horizon"

Text

Schweizer Handelsregister CHE-106.052.527

30/03/2017 EU funding (€1,274,400): CRG International Research Postdoctoral Programme
31/10/2017 EU funding (€15.8M): Liver Investigation: Testing Marker Utility in Steatohepatitis
01/01/2017 EU funding (€20.2M): Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
01/09/2017 EU funding (€20M): Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
01/02/2017 EU funding (€3,549,833): Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
28/08/2017 EU funding (€4,495,523): European Quality In Preclinical Data
01/03/2017 EU funding (€4,684,998): Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060
01/09/2017 EU funding (€8,025,000): Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076
01/03/2017 EU funding (€9,664,970): Big Data 4 Better Hearts - Sofia ref.: 116074
tax haven banner

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Novartis Pharma AG, Basle, Switzerland.

Printing is only available to North Data premium service subscribers.